Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways.
about
Integrative systems biology approaches in asthma pharmacogenomicsFurther evidence supporting a role for gs signal transduction in severe malaria pathogenesisGenome-wide association analysis in asthma subjects identifies SPATS2L as a novel bronchodilator response geneA genome-wide association study of bronchodilator response in asthmaticsPredicting response to short-acting bronchodilator medication using Bayesian networks.The role of pharmacogenomics in improving the management of asthmaA methodology to establish a database to study gene environment interactions for childhood asthma.Factors predicting inhaled corticosteroid responsiveness in African American patients with asthma.Pharmacogenetics and the concept of individualized medicine.Asthma pharmacogenetics and the development of genetic profiles for personalized medicineGenome-wide association study of short-acting β2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3.Association of corticotropin-releasing hormone receptor-2 genetic variants with acute bronchodilator response in asthma.Genetics of allergic diseases.The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use.Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus.Asthma from a pharmacogenomic point of viewThe pharmacogenetics research network: from SNP discovery to clinical drug response.Pharmacogenetics of the response to beta 2 agonist drugs: a systematic overview of the field.Pharmacogenetics of the beta 2-adrenergic receptor gene.Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients.A polymorphism of G-protein coupled receptor kinase5 alters agonist-promoted desensitization of beta2-adrenergic receptors.Pharmacogenetics and the development of personalized approaches for combination therapy in asthma.Genetic predictors of response to therapy in childhood asthma.Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicineA genome-wide association study of bronchodilator response in Latinos implicates rare variants.Inhaled corticosteroid treatment modulates ZNF432 gene variant's effect on bronchodilator response in asthmatics.Multiple facets of cAMP signalling and physiological impact: cAMP compartmentalization in the lung.Pharmacogenetics of beta2 adrenergic receptor agonists in asthma management.Do genetic polymorphisms alter patient response to inhaled bronchodilators?Asthma Pharmacogenomics: 2015 Update.Pharmacogenetics and the treatment of asthma.Review on Pharmacogenetics and Pharmacogenomics Applied to the Study of Asthma.Variable-length poly-C tract polymorphisms of the beta2-adrenergic receptor 3'-UTR alter expression and agonist regulation.Genetic variability of the beta2 adrenergic receptor and asthma exacerbations.Testing and estimating gene-environment interactions in family-based association studies.Pharmacogenetic and pharmacogenomic considerations of asthma treatment.Combined pharmacogenetic effect of ADCY9 and ADRB2 gene polymorphisms on the bronchodilator response to inhaled combination therapy.
P2860
Q26861541-AA00DD51-76BF-4AF9-8CF7-0D9F1B35D5BEQ28473594-3FF61336-0FD0-4565-A41A-52EB9BF6D02BQ28481005-0005CE8C-0C8B-4ED2-8668-F553CD54257AQ28943426-6D1D4913-5070-4ECD-8138-EB20F9169CA7Q33581533-501A8A04-06DB-4193-9045-0E0DA5F9F49AQ33669054-F0005901-16D8-48B2-BE1A-543CEBECED40Q33763915-4190B7CC-56A7-440D-B602-7C27694B299DQ34388432-E6464665-D104-47A3-B548-979F4268BD74Q34562770-B0B34B49-8871-44DA-9D90-FC0773C8C7E6Q35076452-B0ED7E90-3FBE-4175-93C7-BE43C5B83D59Q35261929-A3794FF8-3C55-4E1E-A461-ADB4FFC48F69Q35525863-E84FA220-C7F5-40E8-B251-493F79AC1F31Q35556785-7017C4DF-6CA5-4F75-AA3C-08E597575548Q35923045-8D08A47C-72A4-4332-8A9A-EFABB9AC2B86Q36052666-9D9134D7-F584-46FB-9ECF-46FB5D8AE210Q36734803-EF321632-C391-4994-8813-AA4B2FE267B2Q36752662-885695F0-A24C-42E2-9EDA-53F643C50C09Q36918110-7A27C6FF-CD35-4BE9-87B6-99FDB6DBB608Q36998191-D9E1F848-FF6A-4534-A97D-0C38B43AC790Q37102310-53E810BC-5C30-4A17-BF44-A5322DFCCDCFQ37234459-0D7D8CA2-1355-4B38-AF22-7DF850B43F1FQ37425660-730F90C8-515D-465E-86F8-1ABDC0FB4628Q37523908-C70D4E64-B4D3-4AE2-A1DE-E25743C0EA8FQ37600573-CCC59915-4E11-4788-8B98-0FB6D729FE2FQ37610805-355F22F5-E9EA-42CD-B479-021BE5EE1A96Q37619394-4341CE26-7668-485D-8882-233BA1648A82Q38166604-8F32AB97-6C7F-4434-8048-EC0BD01F11DAQ38196942-B9D5AFD0-ED2F-4F1C-9F3C-B61221BD178DQ38237766-ACF2FAFB-1BBE-4AF9-960C-D0487731C76AQ38542847-7C13011A-659E-464C-AA87-9FED9CEC6BC5Q38646972-C213A68E-1DF5-4E92-853C-EF7DC8C00A67Q38853320-D5BD0D9F-0722-467C-B800-5E17FEC60B20Q40048739-A2B54122-1D6F-41CB-9CCC-8C6E3965091EQ42772710-75C7115E-DCF0-4470-9363-A484588D550FQ44928032-2263482F-14CB-4F18-8362-58A23F89506EQ48220346-97554C01-F04C-4950-A5A4-1D39DEF1306EQ53426295-277C668A-990D-475E-9D4E-D7E022938AF0
P2860
Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Molecular properties and pharm ...... t and corticosteroid pathways.
@ast
Molecular properties and pharm ...... t and corticosteroid pathways.
@en
Molecular properties and pharm ...... t and corticosteroid pathways.
@nl
type
label
Molecular properties and pharm ...... t and corticosteroid pathways.
@ast
Molecular properties and pharm ...... t and corticosteroid pathways.
@en
Molecular properties and pharm ...... t and corticosteroid pathways.
@nl
prefLabel
Molecular properties and pharm ...... t and corticosteroid pathways.
@ast
Molecular properties and pharm ...... t and corticosteroid pathways.
@en
Molecular properties and pharm ...... t and corticosteroid pathways.
@nl
P2093
P2860
P356
P1476
Molecular properties and pharm ...... st and corticosteroid pathways
@en
P2093
Kelan G Tantisira
Kersten M Small
Scott T Weiss
Stephen B Liggett
P2860
P304
P356
10.1093/HMG/DDI175
P577
2005-05-06T00:00:00Z